Physician profile
Eric M Chatman
NPI 1366520298
$2,744.55
in general payments reported to CMS, 2019-2025
11 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $411 · 2021: $660 · 2022: $380 · 2023: $169 · 2024: $259 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $965.62 | 2019-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $523.37 | 2019-2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $288.46 | 2019-2024 | |
| Pfizer INC. | $286.91 | 2019-2021 | |
| Lilly USA, LLC | $165.66 | 2019-2024 | Jardiance, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.33 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $159.78 | 2019-2025 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $84.66 | 2024-2025 | |
| Abbott Laboratories | $82.32 | 2021-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $12.86 | 2023 | Veozah |
| Arbor Pharmaceuticals, INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chatman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.